During the COVID-19 pandemic, the Wellcome Centre for Human Genetics is taking measures to prevent the spread of the disease.
Departments are instructed by the University’s Registrar to continue to work from home where possible, and manage the return to on site working, based on the University guidelines for for risk assessments and work prioritisation.
The University remains open and operating as far as possible with the following restrictions:
- No public access to the University
- On-site activity permitted where it cannot be undertaken remotely, driven by safety, capacity and other factors such as schools reopening/other changes in government guidelines
- Teaching and assessment are undertaken remotely where possible and, depending on government guidelines, gatherings of staff and students only permitted where essential for teaching and assessment to take place
The Wellcome Centre for Human Genetics is a research institute of the Nuffield Department of Medicine at the University of Oxford, funded by the University, Wellcome and numerous other sponsors. It is based in purpose-built laboratories on the University of Oxford’s Biomedical Research Campus in Headington, one of the largest concentrations of biomedical expertise in the world.
With more than 400 active researchers and around 70 employed in administrative and support roles, the Centre is an international leader in genetics, genomics and structural biology.
Adipocyte-like signature in ovarian cancer minimal residual disease identifies metabolic vulnerabilities of tumor initiating cells
Artibani M. et al, (2021), JCI Insight
Small-molecule inhibitors of carboxylesterase Notum
Zhao Y. et al, (2021), Future Medicinal Chemistry
CryoET structures of immature HIV Gag reveal six-helix bundle.
Mendonça L. et al, (2021), Communications biology, 4
Fragment binding to the Nsp3 macrodomain of SARS-CoV-2 identified through crystallographic screening and computational docking.
Schuller M. et al, (2021), Science advances, 7
31 March 2021
Listen now to the 1st episode of "Unheard of - The hidden voices of endometriosis". Co-hosted by WHG DPhil Magda Mareckova and Department for Women's and Reproductive Health DPhil Danielle Perro, they seek answers to the biggest questions posed by the endometriosis community
24 March 2021
The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
9 February 2021
The report involved a survey of 1,000 14-to-18-year-olds on a range of issues including genetics research, medical data usage and COVID-19, gathering their perspectives on the impact such work has – and will have – on their lives
18 January 2021
UK scientists have found that a 7,000-year-old genetic mutation is responsible for a rare form of hereditary motor neuropathy (HMN).
31 December 2020
Congratulations to Sir Dave Stuart, FRS FMedSci, NDM’s Professor of Structural Biology, knighted for services to medical research and the scientific community.